Literature DB >> 2951499

Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age.

D M Mann, P O Yates, B Marcyniuk.   

Abstract

In 15 patients with Alzheimer's disease and in 10 with Down's syndrome at middle age, there was severe atrophy, neurofibrillary degeneration and loss of pigmented dopaminergic nerve cells from ventral tegmental area (A10) whereas nerve cells in neighbouring substantia nigra (A9) were much less affected in all three respects. It is suggested that these findings may represent different patterns of damage within the two systems in these conditions which may relate to the presence of Alzheimer type changes (senile plaques) within their respective projection fields.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2951499      PMCID: PMC1031800          DOI: 10.1136/jnnp.50.3.341

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  32 in total

1.  Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.

Authors:  R C Pearson; M V Sofroniew; A C Cuello; T P Powell; F Eckenstein; M M Esiri; G K Wilcock
Journal:  Brain Res       Date:  1983-12-19       Impact factor: 3.252

2.  Evidence for cholinergic neurites in senile plaques.

Authors:  C A Kitt; D L Price; R G Struble; L C Cork; B H Wainer; M W Becher; W C Mobley
Journal:  Science       Date:  1984-12-21       Impact factor: 47.728

3.  Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type.

Authors:  L L Iversen; M N Rossor; G P Reynolds; R Hills; M Roth; C Q Mountjoy; S L Foote; J H Morrison; F E Bloom
Journal:  Neurosci Lett       Date:  1983-08-19       Impact factor: 3.046

4.  Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain.

Authors:  P L McGeer; E G McGeer; J Suzuki; C E Dolman; T Nagai
Journal:  Neurology       Date:  1984-06       Impact factor: 9.910

5.  Basal nucleus of Meynert. A neuropathological study in Alzheimer's disease, simple senile dementia, Pick's disease and Huntington's chorea.

Authors:  F Tagliavini; G Pilleri
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

6.  Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.

Authors:  T Arendt; V Bigl; A Arendt; A Tennstedt
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

7.  Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease.

Authors:  T Arendt; V Bigl; A Tennstedt; A Arendt
Journal:  Neurosci Lett       Date:  1984-07-13       Impact factor: 3.046

8.  Monoaminergic neurotransmitter systems in presenile Alzheimer's disease and in senile dementia of Alzheimer type.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Clin Neuropathol       Date:  1984 Sep-Oct       Impact factor: 1.368

9.  Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.

Authors:  H Arai; K Kosaka; R Iizuka
Journal:  J Neurochem       Date:  1984-08       Impact factor: 5.372

10.  Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Mech Ageing Dev       Date:  1984 Apr-May       Impact factor: 5.432

View more
  12 in total

1.  Selective loss of nigral neurons in Alzheimer's disease: a morphometric study.

Authors:  T Uchihara; H Kondo; K Kosaka; H Tsukagoshi
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Selective loss of nigral neurons in Pick's disease: a morphometric study.

Authors:  T Uchihara; K Tsuchiya; K Kosaka
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome.

Authors:  Linda D Nelson; Prabha Siddarth; Vladimir Kepe; Kevin E Scheibel; S C Huang; Jorge R Barrio; Gary W Small
Journal:  Arch Neurol       Date:  2011-06

4.  Alzheimer-type pathology in melanin-bleached sections of substantia nigra.

Authors:  T Uchihara; H Kondo; K Ikeda; K Kosaka
Journal:  J Neurol       Date:  1995-08       Impact factor: 4.849

Review 5.  Alzheimer disease.

Authors:  Rudy J Castellani; Raj K Rolston; Mark A Smith
Journal:  Dis Mon       Date:  2010-09       Impact factor: 3.800

6.  The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome.

Authors:  W R Gibb; C Q Mountjoy; D M Mann; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

Review 7.  Understanding How Physical Exercise Improves Alzheimer's Disease: Cholinergic and Monoaminergic Systems.

Authors:  Boyi Zong; Fengzhi Yu; Xiaoyou Zhang; Wenrui Zhao; Peng Sun; Shichang Li; Lin Li
Journal:  Front Aging Neurosci       Date:  2022-05-18       Impact factor: 5.702

8.  Increased CSF HVA response to arecoline challenge in Alzheimer's disease.

Authors:  N Pomara; M Stanley; P A LeWitt; M Galloway; R Singh; D Deptula
Journal:  J Neural Transm Gen Sect       Date:  1992

9.  Extrapyramidal features in advanced Down's syndrome: clinical evaluation and family history.

Authors:  P Vieregge; G Ziemens; M Freudenberg; A Piosinski; A Muysers; B Schulze
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

10.  Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models.

Authors:  Alain D Dekker; Yannick Vermeiren; Christelle Albac; Eva Lana-Elola; Sheona Watson-Scales; Dorota Gibbins; Tony Aerts; Debby Van Dam; Elizabeth M C Fisher; Victor L J Tybulewicz; Marie-Claude Potier; Peter P De Deyn
Journal:  Neurobiol Dis       Date:  2017-06-15       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.